Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

L.A. McKeown

August 13, 2024

News Daily News

Vast Majority of HFrEF Patients Eligible for Vericiguat

L.A. McKeown

February 08, 2023

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Daily News

Better Adherence to Guideline Advice Pays Off After Acute MI

Yael L. Maxwell

March 11, 2020

News Daily News

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Caitlin E. Cox

December 11, 2019

News Daily News

Noninvasive Tests for Chest Pain: New Insight Into Who Benefits Most

Yael L. Maxwell

November 07, 2019

News Daily News

Nighttime Hypertension Drug Dosing May Reduce Risk of CVD

L.A. McKeown

October 23, 2019

News Daily News

Recurrent Events Common Among Young Patients With CAD

Michael O'Riordan

October 11, 2019

News Daily News

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

L.A. McKeown

April 03, 2019

News Daily News

Generic ARBs Linked to Increased Adverse Events

Michael O'Riordan

October 04, 2017

News Daily News

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Michael O'Riordan

September 21, 2017

News Daily News

Debating the ARB/MI Paradox: Is It Real, or Is the Story Incomplete?

Michael O'Riordan

June 05, 2017

News Daily News

Yet Another Set of Hypertension Guidelines Sow Confusion Surrounding BP Targets in Older Patients

Michael O'Riordan

January 17, 2017

News Daily News

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

Michael O'Riordan

October 18, 2016

News Daily News

Since COURAGE, Little Change in Optimal Medical Therapy for Stable PCI Patients

Caitlin E. Cox

May 10, 2011

Advertisement

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

Vast Majority of HFrEF Patients Eligible for Vericiguat

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Better Adherence to Guideline Advice Pays Off After Acute MI

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Noninvasive Tests for Chest Pain: New Insight Into Who Benefits Most

Nighttime Hypertension Drug Dosing May Reduce Risk of CVD

Recurrent Events Common Among Young Patients With CAD

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

Generic ARBs Linked to Increased Adverse Events

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Debating the ARB/MI Paradox: Is It Real, or Is the Story Incomplete?

Yet Another Set of Hypertension Guidelines Sow Confusion Surrounding BP Targets in Older Patients

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

Since COURAGE, Little Change in Optimal Medical Therapy for Stable PCI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content